Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Michael A White
Affiliation
University of Georgia
ORCID
Career Start Year
1994
Papers
143
H Index
59
Expertise
CM4AI Collaborator
Trey Ideker (CM4AI)
PMID
Paper Title
Journal Title
Published Year
35635635
Meiotic pairing and double-strand break formation along the heteromorphic threespine stickleback sex chromosomes.
Chromosome Res
2022
35838183
Snail acetylation by autophagy-derived acetyl-coenzyme A promotes invasion and metastasis of KRAS-LKB1 co-mutated lung cancer cells.
Cancer Commun (Lond)
2022
35577641
The evolution of gene regulation on sex chromosomes.
Trends Genet
2022
34348154
Exocyst protein subnetworks integrate Hippo and mTOR signaling to promote virus detection and cancer.
Cell Rep
2021
33598708
Improved contiguity of the threespine stickleback genome using long-read sequencing.
G3 (Bethesda)
2021
34970648
Blastocyst development after fertilization with in vitro spermatids derived from nonhuman primate embryonic stem cells.
F S Sci
2021
34520734
Expanding control of the tumor cell cycle with a CDK2/4/6 inhibitor.
Cancer Cell
2021
34131005
Long-read RNA sequencing reveals widespread sex-specific alternative splicing in threespine stickleback fish.
Genome Res
2021
32512502
An in vivo functional genomics screen of nuclear receptors and their co-regulators identifies FOXA1 as an essential gene in lung tumorigenesis.
Neoplasia
2020
31964871
High-throughput identification of protein functional similarities using a gene-expression-based siRNA screen.
Sci Data
2020
33120942
A Gene Expression High-Throughput Screen (GE-HTS) for Coordinated Detection of Functionally Similar Effectors in Cancer.
Cancers (Basel)
2020
31378711
A Genome-wide Functional Signature Ontology Map and Applications to Natural Product Mechanism of Action Discovery.
Cell Chem Biol
2019
29784984
Author Correction: Small-molecule TFEB pathway agonists that ameliorate metabolic syndrome in mice and extend C. elegans lifespan.
Nat Commun
2018
33313341
Inferring Genome-Wide Interaction Networks Using the Phi-Mixing Coefficient, and Applications to Lung and Breast Cancer (Invited Paper).
IEEE Trans Mol Biol Multiscale Commun
2018
29854321
Correction: Mitochondrial clearance by the STK38 kinase supports oncogenic Ras-induced cell transformation.
Oncotarget
2018
29775598
Selective Cytotoxicity of the NAMPT Inhibitor FK866 Toward Gastric Cancer Cells With Markers of the Epithelial-Mesenchymal Transition, Due to Loss of NAPRT.
Gastroenterology
2018
29491475
A Functional Signature Ontology (FUSION) screen detects an AMPK inhibitor with selective toxicity toward human colon tumor cells.
Sci Rep
2018
29681454
Chemistry-First Approach for Nomination of Personalized Treatment in Lung Cancer.
Cell
2018
27813172
Digitization of Endocytic pH by Hybrid Ultra-pH-Sensitive Nanoprobes at Single-Organelle Resolution.
Adv Mater
2017
28361685
Sparse feature selection for classification and prediction of metastasis in endometrial cancer.
BMC Genomics
2017
28455392
Biomarker Accessible and Chemically Addressable Mechanistic Subtypes of BRAF Melanoma.
Cancer Discov
2017
28102363
SMARCA4-inactivating mutations increase sensitivity to Aurora kinase A inhibitor VX-680 in non-small cell lung cancers.
Nat Commun
2017
28294973
FUSION-Guided Hypothesis Development Leads to the Identification of Nâ¶,Nâ¶-Dimethyladenosine, a Marine-Derived AKT Pathway Inhibitor.
Mar Drugs
2017
28205554
The OncoPPi network of cancer-focused protein-protein interactions to inform biological insights and therapeutic strategies.
Nat Commun
2017
28416792
Corrigendum: The OncoPPi network of cancer-focused protein-protein interactions to inform biological insights and therapeutic strategies.
Nat Commun
2017
29273768
Small-molecule TFEB pathway agonists that ameliorate metabolic syndrome in mice and extend C. elegans lifespan.
Nat Commun
2017
28647672
Therapeutic Targeting of Nuclear Export Inhibition in Lung Cancer.
J Thorac Oncol
2017
28716898
TBK1 Provides Context-Selective Support of the Activated AKT/mTOR Pathway in Lung Cancer.
Cancer Res
2017
27612550
Investigation of endosome and lysosome biology by ultra pH-sensitive nanoprobes.
Adv Drug Deliv Rev
2017
26755624
Computational discovery of pathway-level genetic vulnerabilities in non-small-cell lung cancer.
Bioinformatics
2016
26511490
Cancer-Specific Production of N-Acetylaspartate via NAT8L Overexpression in Non-Small Cell Lung Cancer and Its Potential as a Circulating Biomarker.
Cancer Prev Res (Phila)
2016
27680702
XPO1-dependent nuclear export is a druggable vulnerability in KRAS-mutant lung cancer.
Nature
2016
27334922
Inhibition of Ral GTPases Using a Stapled Peptide Approach.
J Biol Chem
2016
27426302
Discovery of novel TAOK2 inhibitor scaffolds from high-throughput screening.
Bioorg Med Chem Lett
2016
27283898
Mitochondrial clearance by the STK38 kinase supports oncogenic Ras-induced cell transformation.
Oncotarget
2016
27273865
KSR1 and EPHB4 Regulate Myc and PGC1β To Promote Survival of Human Colon Tumors.
Mol Cell Biol
2016
27034613
Optimized Prediction of Extreme Treatment Outcomes in Ovarian Cancer.
Cancer Inform
2016
26788852
Exploiting the CRISPR/Cas9 PAM Constraint for Single-Nucleotide Resolution Interventions.
PLoS One
2016
25519225
Genetic mutation of p53 and suppression of the miR-17⿼92 cluster are synthetic lethal in non-small cell lung cancer due to upregulation of vitamin D Signaling.
Cancer Res
2015
26437053
A nanobuffer reporter library for fine-scale imaging and perturbation of endocytic organelles.
Nat Commun
2015
26655797
A genome-scale screen reveals context-dependent ovarian cancer sensitivity to miRNA overexpression.
Mol Syst Biol
2015
26432890
Cutting Edge: Inhibiting TBK1 by Compound II Ameliorates Autoimmune Disease in Mice.
J Immunol
2015
26351140
AMPK Promotes Aberrant PGC1β Expression To Support Human Colon Tumor Cell Survival.
Mol Cell Biol
2015
26372654
Synthesis and structure-activity studies of the V-ATPase inhibitor saliphenylhalamide (SaliPhe) and simplified analogs.
Bioorg Med Chem Lett
2015
26283729
Role of the Exocyst Complex Component Sec6/8 in Genomic Stability.
Mol Cell Biol
2015
25867045
Mode of action and pharmacogenomic biomarkers for exceptional responders to didemnin B.
Nat Chem Biol
2015
25855536
Whole-exome sequencing of pancreatic cancer defines genetic diversity and therapeutic targets.
Nat Commun
2015
25679763
Degradation of AMPK by a cancer-specific ubiquitin ligase.
Cell
2015
24530809
Nuclear trafficking in health and disease.
Curr Opin Cell Biol
2014
25497091
MCT4 defines a glycolytic subtype of pancreatic cancer with poor prognosis and unique metabolic dependencies.
Cell Rep
2014
1 - 50 of 143
Column Actions
Search
Recommended Authors
Alexandre Rosa Campos
Sanford Burnham Prebys Medical Discovery Institute
Career Start Year
2015
Number of shared co-authors
0
Peter S Winter
Dana-Farber Cancer Institute, Brigham and Women's Hospital and Harvard Medical School
Career Start Year
2014
Number of shared co-authors
1
Florent Dingli
Institut Curie, PSL Research University
Career Start Year
2011
Number of shared co-authors
1
Frederick S Vizeacoumar
College of Medicine, University of Saskatchewan
Career Start Year
2010
Number of shared co-authors
0
Genevi??ve Lavoie
Institute for Research in Immunology and Cancer (IRIC)
Career Start Year
2004
Number of shared co-authors
0
Sourav Bandyopadhyay
University of California San Francisco
Career Start Year
2004
Number of shared co-authors
7
Barak Rotblat
Ben-Gurion University of the Negev
Career Start Year
2002
Number of shared co-authors
2
Mariano J Alvarez
Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center
Career Start Year
2000
Number of shared co-authors
9
Kevin R Brown
College Street, University of Toronto
Career Start Year
2000
Number of shared co-authors
3
Rachel Toth
University of Dundee
Career Start Year
1999
Number of shared co-authors
2
Stephane Angers
Department of Pharmaceutical Sciences, University of Toronto
Career Start Year
1999
Number of shared co-authors
1
Jason Moffat
University of Toronto
Career Start Year
1997
Number of shared co-authors
4
Kaylene J Simpson
The University of Melbourne, Peter MacCallum Cancer Centre
Career Start Year
1996
Number of shared co-authors
2
Krister Wennerberg
University of Copenhagen
Career Start Year
1994
Number of shared co-authors
8
Manfred Koegl
Boehringer Ingelheim RCV GmbH & Co. KG
Career Start Year
1993
Number of shared co-authors
1
John Easton
St Jude Children's Research Hospital
Career Start Year
1991
Number of shared co-authors
5
Glenn S Cowley
Broad Institute of Harvard and MIT
Career Start Year
1990
Number of shared co-authors
11
Todd R Golub
Broad Institute of MIT and Harvard
Career Start Year
1989
Number of shared co-authors
11
E Alejandro Sweet-Cordero
University of California San Francisco
Career Start Year
1989
Number of shared co-authors
5
Kun-Liang Guan
University of California San Diego
Career Start Year
1988
Number of shared co-authors
4
Daniel S Peeper
Netherlands Cancer Institute
Career Start Year
1987
Number of shared co-authors
1
Michael F Moran
Hospital for Sick Children, University of Toronto
Career Start Year
1985
Number of shared co-authors
0
Jorge Silvio Gutkind
Moores Cancer Center, University of California San Diego
Career Start Year
1984
Number of shared co-authors
3
Andrew D Cherniack
Dana-Farber Cancer Institute
Career Start Year
1984
Number of shared co-authors
17
Stephen J Elledge
Howard Hughes Medical Institute, Brigham and Women's Hospital, Harvard Medical School
Career Start Year
1982
Number of shared co-authors
5
J. Wade Harper
Harvard Medical School
Career Start Year
1981
Number of shared co-authors
4
Ze'ev Ronai
Cancer Center, Sanford Burnham Prebys Medical Discovery Institute
Career Start Year
1981
Number of shared co-authors
2
Francisca Vazquez
Broad Institute of MIT and Harvard
Career Start Year
1979
Number of shared co-authors
11
Gordon B Mills
Knight Cancer Institute, Oregon Health and Sciences University
Career Start Year
1976
Number of shared co-authors
26
Frank McCormick
Frederick National Laboratory for Cancer Research
Career Start Year
1975
Number of shared co-authors
9
row(s) 1 - 30 of 30
Collaborators
John D Minna
University of Texas Southwestern Medical Center at Dallas
Co-authored papers
18
Hyun Seok Kim
Seoul National University
Co-authored papers
18
Saurabh Mendiratta
University of Texas Southwestern Medical Center
Co-authored papers
12
John B MacMillan
University of California
Co-authored papers
11
Robert E Lewis
University of Nebraska Medical Center
Co-authored papers
9
Malia B Potts
St. Jude Children's Research Hospital
Co-authored papers
8
Yi-Hung Ou
The First Affiliated Hospital of Guangdong Pharmaceutical University
Co-authored papers
7
Kurt W Fisher
University of Nebraska Medical Center
Co-authored papers
7
Melanie H Cobb
Co-authored papers
7
Yingming Zhao
Co-authored papers
7
Michael Peyton
Hamon Center for Therapeutic Oncology Research, UT Southwestern Medical Center
Co-authored papers
6
Guanghua Xiao
The University of Texas Southwestern Medical Center
Co-authored papers
5
Yang Xie
Quantitative Biomedical Research Center
Co-authored papers
5
Beatriz M A Fontoura
University of Texas Southwestern Medical Center
Co-authored papers
5
Youcai Hu
UT Southwestern Medical Center
Co-authored papers
3
Mehmet Eren Ahsen
Gies College of Business, University of Illinois at Urbana-Champaign.
Co-authored papers
3
Ralf Kittler
McDermott Center for Human Growth and Development.
Co-authored papers
2
David A Wheeler
Baylor College of Medicine
Co-authored papers
2
Rahul K Kollipara
McDermott Center for Human Growth and Development.
Co-authored papers
2
Lynda Chin
Co-authored papers
2
Adolfo Garc??a-Sastre
Icahn School of Medicine at Mount Sinai
Co-authored papers
2
Lee A D Cooper
Northwestern Feinberg School of Medicine
Co-authored papers
2
Anil K Sood
The University of Texas MD Anderson Cancer Center
Co-authored papers
2
GuemHee Baek
UT Southwestern Medical Center
Co-authored papers
2
Mireya L Herrera-Herrera
Universidad Autonoma de San Luis Potosi
Co-authored papers
2
Chad V Pecot
University of North Carolina at Chapel Hill
Co-authored papers
2
Keith A Baggerly
The University of Texas MD Anderson Cancer Center
Co-authored papers
2
Min Luo
Institute of Biomedical Science and Children's Hospital, Fudan University
Co-authored papers
2
Didier Surdez
Balgrist University Hospital, University of Zurich (UZH)
Co-authored papers
2
Wei Zhang
Montefiore Medical Center
Co-authored papers
1
1 - 30